Search Results - Recto, Rhona

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Clinical and biomarker responses to BI 655064, an antagonistic anti-CD40 antibody, in patients with active lupus nephritis: a randomized, double-blind, placebo-controlled, phase II trial

    Clinical and biomarker responses to BI 655064, an antagonistic anti-CD40 antibody, in patients with active lupus nephritis: a randomized, double-blind, placebo-controlled, phase II... by Jayne, David R, Steffgen, Jürgen, Romero-Diaz, Juanita, Bajema, Ingeborg, Boumpas, Dimitrios T, Noppakun, Kajohnsak, Amano, Hirofumi, Gomez, Harold Michael, Satirapoj, Bancha, Avihingsanon, Yingyos, Chawanasuntorapoj, Ratana, Madero, Magdalena, Naumnik, Beata, Recto, Rhona, Fagan, Nora, Revollo, Ivette, Wu, Jing, Visvanathan, Sudha, Furie, Richard

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    FC 049A RANDOMISED DOSE RANGING, PLACEBO-CONTROLLED, PHASE II STUDY ASSESSING THE EFFICACY AND SAFETY OF BI 655064, AN ANTAGONISTIC ANTI-CD40 ANTIBODY, IN PATIENTS WITH LUPUS NEPHRITIS

    FC 049A RANDOMISED DOSE RANGING, PLACEBO-CONTROLLED, PHASE II STUDY ASSESSING THE EFFICACY AND SAFETY OF BI 655064, AN ANTAGONISTIC ANTI-CD40 ANTIBODY, IN PATIENTS WITH LUPUS NEPHR... by Jayne, David, Furie, Richard, Romero-Diaz, Juanita, Amano, Hirofumi, Noppakun, Kajohnsak, Gomez, Harold Michael, Recto, Rhona, Belsack, Valérie, Fagan, Nora, Padula, Steven, Revollo, Ivette, Wu, Jing, Visvanathan, Sudha, Steffgen, Jürgen

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: